Cleveland, Ohio From the Department of Plastic Surgery, University Hospitals Case Medical Center, and Case Western Reserve University School of Medicine.
Plast Reconstr Surg. 2012 May;129(5):1113-1119. doi: 10.1097/PRS.0b013e31824a2c31.
This study was designed to compare the efficacy of the transpalpebral versus endoscopic approach to decompression of the supraorbital and supratrochlear nerves in patients with frontal migraine headaches.
The medical charts of 253 patients who underwent surgery for frontal migraine headaches were reviewed. These patients underwent either transpalpebral nerve decompression (n = 62) or endoscopic nerve decompression (n = 191). Preoperative and 12-month or greater postoperative migraine frequency, duration, and intensity were analyzed to determine the success of the surgeries.
Forty-nine of 62 patients (79 percent) in the transpalpebral nerve decompression group and 170 of 191 patients (89 percent) who underwent endoscopic nerve decompression experienced a successful outcome (at least a 50 percent decrease in migraine frequency, duration, or intensity) after 1 year from surgery. Endoscopic nerve decompression had a significantly higher success rate than transpalpebral nerve decompression (p < 0.05). Thirty-two patients (52 percent) in the transpalpebral nerve decompression group and 128 patients (67 percent) who underwent endoscopic nerve decompression observed elimination of migraine headaches. The elimination rate was significantly higher in the endoscopic nerve decompression group than in the transpalpebral nerve decompression group (p < 0.03).
Endoscopic nerve decompression was found to be more successful at reducing or eliminating frontal migraine headaches than transpalpebral nerve decompression and should be selected as the first choice whenever it is anatomically feasible.
CLINICAL QUESTION/LEVEL OF EVIDENCE: Therapeutic, III.
本研究旨在比较经皮与经眶内镜两种眶上和滑车上神经减压术治疗额部偏头痛的疗效。
回顾了 253 例因额部偏头痛接受手术治疗的患者的病历。这些患者分别接受经皮神经减压术(n=62)或经眶内镜神经减压术(n=191)。分析术前及术后 12 个月或更长时间的偏头痛发作频率、持续时间和强度,以确定手术的疗效。
经皮神经减压组 62 例患者中有 49 例(79%),经眶内镜神经减压组 191 例患者中有 170 例(89%)在术后 1 年时取得成功(偏头痛发作频率、持续时间或强度至少降低 50%)。经眶内镜神经减压的成功率明显高于经皮神经减压(p<0.05)。经皮神经减压组 32 例(52%),经眶内镜神经减压组 128 例(67%)患者偏头痛完全消除。经眶内镜神经减压组的消除率明显高于经皮神经减压组(p<0.03)。
与经皮神经减压相比,经眶内镜神经减压在减轻或消除额部偏头痛方面更有效,只要在解剖上可行,应作为首选。
临床问题/证据水平:治疗,III 级。